The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clonal dominance of EGFR and efficacy of EGFR-tyrosine kinase inhibitors (EGFR-TKIs) in NSCLC.
 
Xinghao Ai
No Relationships to Disclose
 
Rongrong Chen
Employment - Geneplus
Leadership - Geneplus
 
Jiuwei Cui
No Relationships to Disclose
 
Jiexia Zhang
No Relationships to Disclose
 
Wen Lin
No Relationships to Disclose
 
Congying Xie
No Relationships to Disclose
 
Xiaohua HU
No Relationships to Disclose
 
Junping Zhang
No Relationships to Disclose
 
Xiaodong Jiao
No Relationships to Disclose
 
Chuangzhou Rao
No Relationships to Disclose
 
Weihua Yang
No Relationships to Disclose
 
Lianpeng Chang
Employment - Geneplus
Leadership - Geneplus
 
Xuefeng Xia
Employment - Geneplus
Leadership - Geneplus
 
Xin Yi
Employment - Geneplus
Leadership - Geneplus
Stock and Other Ownership Interests - Geneplus
 
Shun Lu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Hutchison MediPharma; Roche; Simcere
Speakers' Bureau - AstraZeneca; Hansoh; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; HenRui; Hutchison MediPharma; Roche